Journal of Medical Internet Research· 2026Q1
A Hybrid Rule-Based and Machine Learning–Based Clinical Decision Support System to Support Prescription Review: Development and External Validation Study
- 0citations
- Q1SCImago
- 2026year
Short summary
A hybrid clinical decision support system (CDSS) combining rule-based logic and machine learning (CatBoost classifier) achieved high accuracy in identifying anticoagulant prescriptions needing pharmacist intervention, with 86.4% of alerts deemed clinically useful in internal validation and 18.8%-57.1% requiring intervention in external validation across two hospitals.
AI-generated from the title and abstract; the full text is not read.
Key points
- Developed a hybrid CDSS integrating rule-based logic and a CatBoost machine learning classifier for anticoagulant prescription review.
- The system includes 44 patient-specific rules and 1129 drug-drug interaction rules.
- Internal validation showed 86.4% of alerts were clinically useful, with 13.6% requiring pharmacist intervention.
- External validation across two hospitals yielded alert rates of 22.6%-32.1%, with 18.8%-57.1% of alerts requiring intervention.
- The hybrid CDSS demonstrated strong discrimination (AUC 0.871-0.963) and identified no false negatives.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Background Anticoagulants are high-alert medications with substantial risk of serious bleeding, yet dosing and prescribing errors remain common. Although clinical decision support systems (CDSSs) can mitigate these errors, their impact is constrained by alert fatigue and limited interpretability. Objective We developed and validated a hybrid CDSS that integrates rule-based logic with machine learning to improve the safe use of anticoagulants. Methods This multicenter study used electronic health record data on anticoagulant prescriptions from 3 tertiary hospitals (1 for system development and internal validation and 2 for external validation). The hybrid CDSS combined a knowledge-based rule engine with a machine learning model trained to predict whether an anticoagulant prescription would require pharmacist intervention. The system was iteratively refined through pilot testing, internal validation, and external validation. Results A total of 75,200 anticoagulant prescriptions were used for model development. The final hybrid CDSS comprised 44 patient-specific rules and 1129 drug-drug interaction rules, combined with a CatBoost classifier (version 1.2.5; Yandex) for alert prioritization. During internal validation, 88 (18.9%) alerts were generated; all were technically correct; 88.6% (n=78) were deemed clinically relevant; 86.4% (n=76) were considered clinically useful; and 13.6% (n=12) required pharmacist intervention. In external validation across 2 hospitals, alert rates ranged from 22.6% (7/31) to 32.1% (310/966), with 18.8% (22/117) to 57.1% (4/7) of alerts requiring pharmacist intervention. The hybrid CDSS showed strong discrimination (area under the receiver operating characteristic curve 0.871‐0.963). No false negatives were identified, but the estimates should be interpreted cautiously given the short validation periods and limited number of intervention-requiring prescriptions. Conclusions A hybrid CDSS integrating rule-based logic with machine learning demonstrated high technical accuracy and clinical relevance across multiple institutions, suggesting its potential as a practical tool for supporting pharmacist-led anticoagulant prescription review.
The authors' abstract, as published at the source. Journal of Medical Internet Research, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Health Information Management
Health Information ManagementHealth Professions